Polymorphism of the angiotensin-converting enzyme gene in end-stage renal failure patients

Filippo Aucella, Mimmo Vigilante, Maurizio Margaglione, Elvira Grandone, Annamaria Del Popolo, Mauro Forcella, Deni Procaccini, Giovanna Salatino, Antonio Passione, Maria Ktena, Alva De Min, Carmine Stallone

Research output: Contribution to journalArticlepeer-review


The plasma levels of angiotensin-converting enzyme (ACE) are modulated by the insertion (I)/deletion (D) polymorphism within the ACE gene locus. An association between progressive renal disease, raised cardiovascular risk, and ACE plasma levels has been shown. To evaluate the genotype frequencies of the I/D polymorphism in terminal renal failure, we have enrolled 341 dialysis patients (321 on hemodialysis and 20 on peritoneal dialysis) in a district of southern Italy (Foggia). As controls, 1307 subjects from the same area have been enrolled. Genomic DNA was obtained from leukocytes, and the ACE I/D polymorphism was determined by polymerase chain reaction. Among uremics, 151 subjects (44.3%) carried the DD genotype, 149 (43.7%) the ID, and 41 (12.0%) the II genotype. In controls, 560 subjects (42.8%) had the DD genotype, 577 (44.1%) the ID, and 170 (13.1%) the II genotype (p = n.s.). Among patients, the frequency of DD subjects was higher in men (48.3%) than in women (39.7%, p <0.01). A slight different frequency of the DD genotype was found according to the duration of dialysis treatment: 47.5% in patients on dialysis up to 60 months and 41.7 and 40.6% in those with a dialytic age of 60-120 and > 120 months, respectively (p for trend: 0.53). Patients with or without cardiovascular diseases, such as hypertension, left ventricular hypertrophy, coronary artery disease, and chronic cardiac failure, did not exhibit any difference in ACE I/D allele and genotype frequencies (p always > 0.05). In conclusion, frequencies of the ACE DD genotype were similar in uremics and in controls and did not differ between patients with and without cardiovascular diseases. A nonsignificant inverse relationship with the time spent on dialysis was observed, suggesting that ACE I/D polymorphism may influence the cardiovascular death rate. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish
Pages (from-to)54-59
Number of pages6
Issue number1
Publication statusPublished - 2000


  • Angiotensin-converting enzyme
  • Dialysis
  • Gene
  • Polymorphism

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Polymorphism of the angiotensin-converting enzyme gene in end-stage renal failure patients'. Together they form a unique fingerprint.

Cite this